RNA
Atrium Therapeutics, Inc. Common Stock
NASDAQ: RNA · HEALTHCARE · BIOTECHNOLOGY
$12.99
+3.51% today
Updated 2026-04-29
Market cap
$201.54M
P/E ratio
—
P/S ratio
10.82x
EPS (TTM)
$-4.48
Dividend yield
—
52W range
$12 – $17
Volume
1.5M
Atrium Therapeutics, Inc. Common Stock (RNA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.27M | $10.36M | $13.09M | $379000.00 | $2.32M | $6.79M | $9.33M | $9.22M | $9.56M | $10.90M | $18.62M |
| Revenue growth (YoY) | — | -8.1% | +26.4% | -97.1% | +511.9% | +192.7% | +37.4% | -1.1% | +3.6% | +14.0% | +70.9% |
| Cost of revenue | $25.28M | $22.75M | $32.51M | $8.44M | $14.54M | $37.60M | $639000.00 | $1.39M | $2.10M | $2.78M | $4.15M |
| Gross profit | — | — | — | $-8.06M | $2.32M | $6.79M | $9.33M | $9.22M | $7.46M | $10.90M | $18.62M |
| Gross margin | 0.0% | 0.0% | 0.0% | -2125.9% | 100.0% | 100.0% | 100.0% | 100.0% | 78.0% | 100.0% | 100.0% |
| R&D | $19.91M | $18.98M | $25.44M | $8.44M | $14.54M | $37.60M | $101.18M | $150.40M | $190.97M | $303.59M | $53.76M |
| SG&A | — | — | — | $2.44M | $5.11M | $13.46M | $26.20M | $37.73M | $54.19M | $86.24M | $41.68M |
| Operating income | — | — | — | $-10.50M | $-17.33M | $-44.28M | $-118.05M | $-178.91M | $-235.60M | $-378.94M | $-76.81M |
| Operating margin | 0.0% | 0.0% | 0.0% | -2769.9% | -747.4% | -652.4% | -1265.8% | -1939.6% | -2464.4% | -3477.4% | -412.6% |
| EBITDA | — | — | — | $-10.12M | $-17.00M | $-43.90M | $-117.41M | $-177.53M | $-233.50M | $-376.16M | $-76.49M |
| EBITDA margin | 0.0% | 0.0% | 0.0% | -2668.9% | -733.0% | -646.9% | -1259.0% | -1924.6% | -2442.4% | -3452.0% | -410.8% |
| EBIT | — | — | — | $-10.50M | $-17.35M | $-44.28M | $-118.05M | $-178.91M | $-235.60M | $-378.94M | $-76.81M |
| Interest expense | $0.00 | $0.00 | $0.00 | $718000.00 | $7.39M | $209000.00 | $639000.00 | $5.69M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | — | — | $-11.93M | $-24.73M | $-43.98M | $-117.37M | $-169.08M | $-212.22M | $-322.30M | $-76.68M |
| Net income growth (YoY) | — | — | — | — | -107.3% | -77.8% | -166.9% | -44.1% | -25.5% | -51.9% | +76.2% |
| Profit margin | 0.0% | 0.0% | 0.0% | -3148.8% | -1066.6% | -648.0% | -1258.5% | -1833.0% | -2219.9% | -2957.7% | -411.9% |